Bristol-Myers Squibb Rest Of World — Property, plant and equipment increased by 1.5% to $7.66B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $7.21B to $7.66B. Over 5 years (FY 2020 to FY 2025), Rest Of World — Property, plant and equipment shows an upward trend with a 5.1% CAGR.
An increase suggests expansion of international manufacturing or research infrastructure, while a decrease may indicate asset divestiture, depreciation, or a shift toward outsourcing international production.
This metric represents the net book value of tangible long-lived assets, such as manufacturing facilities, laboratories,...
Peers in the pharmaceutical industry typically report geographic breakdowns of fixed assets to demonstrate their global manufacturing footprint and regulatory compliance infrastructure.
bmy_segment_rest_of_world_property_plant_and_equipment| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.80B | $5.87B | $6.05B | $163.00M | $6.05B | $5.97B | $6.04B | $6.26B | $6.28B | $6.36B | $6.48B | $6.65B | $6.75B | $6.85B | $6.90B | $7.14B | $7.21B | $7.37B | $7.35B | $7.54B | $7.66B |
| QoQ Change | — | +1.3% | +3.1% | -97.3% | >999% | -1.3% | +1.1% | +3.6% | +0.4% | +1.2% | +2.0% | +2.5% | +1.6% | +1.4% | +0.8% | +3.4% | +1.1% | +2.2% | -0.3% | +2.6% | +1.5% |
| YoY Change | — | — | — | — | — | +3.0% | +2.8% | +3.4% | +3.8% | +6.4% | +7.4% | +6.3% | +7.5% | +7.7% | +6.5% | +7.4% | +6.9% | +7.7% | +6.5% | +5.7% | +6.2% |